|
|
Substance Name: Glisoxepide [INN:BAN:DCF]
RN: 25046-79-1
UNII: H7SC0I332I
InChIKey: ZKUDBRCEOBOWLF-UHFFFAOYSA-N
Note
- Oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.
Classification Code
- Drug / Therapeutic Agent
Molecular Formula
- C20-H27-N5-O5-S
Molecular Weight
- 449.529
- All
- Links to Resources
- Names & Synonyms
- Registry Numbers
- Structure Descriptors
- Toxicity
- Physical Properties
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Other Resources (Internet Locators)
Search for this InChIKey on the Web
Names and Synonyms
Name of Substance
- Glisoxepide
- Glisoxepide [INN:BAN:DCF]
Synonyms
- 1-(Hexahydro-1H-azepin-1-yl)-3-((p-(2-(5-methyl-3-isoxazolecarboxamido)ethyl)phenyl)sulfonyl)urea
- Bay B 4231
- BRN 0592109
- BS 4231
- EINECS 246-579-5
- FBB 4231
- Glisepin
- Glisoxepid
- Glisoxepida
- Glisoxepida [INN-Spanish]
- Glisoxepida [Spanish]
- Glisoxepide
- Glisoxepidum
- Glisoxepidum [INN-Latin]
- Pro-Diaban
- RP 22410
- UNII-H7SC0I332I
Systematic Names
- 1-(Hexahydro-1H-azepin-1-yl)-3-((p-(2-(5-methyl-3-isoxazolecarboxamido)ethyl)phenyl)sulfonyl)urea
- 3-Isoxazolecarboxamide, N-(2-(4-(((((hexahydro-1H-azepin-1-yl)amino)carbonyl)amino)sulfonyl)phenyl)ethyl)-5-methyl-
- Glisoxepide
Registry Numbers
CAS Registry Number
- 25046-79-1
FDA UNII
- H7SC0I332I
System Generated Number
- 0025046791
Structure Descriptors
InChI
InChI=1S/C20H27N5O5S/c1-15-14-18(23-30-15)19(26)21-11-10-16-6-8-17(9-7-16)31(28,29)24-20(27)22-25-12-4-2-3-5-13-25/h6-9,14H,2-5,10-13H2,1H3,(H,21,26)(H2,22,24,27)InChIKey
ZKUDBRCEOBOWLF-UHFFFAOYSA-NSmiles
Cc1onc(c1)Toxicity
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
cat | LD50 | oral | > 4gm/kg (4000mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 24, Pg. 409, 1974. | |
dog | LD50 | oral | > 2gm/kg (2000mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 24, Pg. 409, 1974. | |
mouse | LD50 | intravenous | 283mg/kg (283mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: CYANOSIS LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES | Arzneimittel-Forschung. Drug Research. Vol. 24, Pg. 409, 1974. |
mouse | LD50 | oral | > 10gm/kg (10000mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 24, Pg. 409, 1974. | |
rabbit | LD50 | oral | > 4gm/kg (4000mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 24, Pg. 409, 1974. | |
rat | LD50 | intravenous | 196mg/kg (196mg/kg) | LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: CYANOSIS | Arzneimittel-Forschung. Drug Research. Vol. 24, Pg. 409, 1974. |
rat | LD50 | oral | > 10gm/kg (10000mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 24, Pg. 409, 1974. |
Physical Properties
Physical Property | Value | Units | Temp (deg C) | Source |
---|---|---|---|---|
Melting Point | 189 | deg C | EXP | |
log P (octanol-water) | 2.500 | (none) | EST | |
Atmospheric OH Rate Constant | 5.16E-11 | cm3/molecule-sec | 25 | EST |
Physical property data is provided to ChemIDplus by SRC, Inc.